Benjamin Halladay

ESPR

Benjamin Halladay serves as officer: Chief Financial Officer at Esperion Therapeutics, Inc. (ESPR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

10 trades

$85.6K

Net Position

Net Seller

$85.6K

Companies Traded

ESPR

Active Period

Dec 2024 – Mar 2026

10 total trades

Most Recent

Sell ESPR

Mar 18, 2026 · $17.4K

Benjamin Halladay's Insider Trading at Esperion Therapeutics, Inc. (ESPR)

Buys

0 · $0.00

Sells

10 · $85.6K

Total Shares Bought

Total Shares Sold

34,855

ESPR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 18, 2026	Sell	6,424	$2.70	$17.4K	713,602
Dec 17, 2025	Sell	7,337	$3.67	$26.9K	467,525
Sep 17, 2025	Sell	7,046	$2.81	$19.8K	474,862
Jul 17, 2025	Sell	11	$1.12	$12.27	0
Jun 17, 2025	Sell	7,229	$1.15	$8.3K	0
Apr 17, 2025	Sell	8	$0.96	$7.71	0
Mar 18, 2025	Sell	3,535	$1.48	$5.2K	0
Feb 19, 2025	Sell	11	$1.86	$20.46	240,671
Jan 17, 2025	Sell	9	$2.27	$20.39	240,682
Dec 17, 2024	Sell	3,245	$2.42	$7.9K	240,691

Related Insiders

Sheldon L. Koenig

President and CEO

ESPRSell · Mar 18, 2026

Benjamin Looker

officer: General Counsel

ESPRSell · Mar 18, 2026

Explore More Insider Trading Data

ESPR Insider Trading Activity

View all insider trades at Esperion Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity